Amy Tiersten, MD

img_Amy Tiersten
PROFESSOR | Medicine, Hematology and Medical Oncology
Are you a patient?
Specialties
Internal Medicine, Cancer (Oncology)
Research Topics
Anti-Tumor Therapy

MD, New York University School of Medicine

BA, Barnard College/Columbia University

Residency, Internal Medicine, Mount Sinai Hospital

Fellowship, Hematology & Oncology, Memorial Sloan-Kettering Cancer Center

Certifications

American Board of Internal Medicine

2005

New award

New York University School of Medicine, Division of Oncology

2000

New award

Columbia University College of Physicians & Surgeons

1996

New award

American Society of Clinical Oncology

Publications

Selected Publications

A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer. Keith L. Knutson, Hala Abu-Fares, Patricia Keating, Matthew S. Block, Nadine Norton, Courtney L. Erskine, Davitte Cogen, Hadeel Assad, Stephanie L. Graff, Erika P. Hamilton, Hyo S. Han, Kristi J. McIntyre, Aziza Nassar, Joseph A. Sparano, Amy Tiersten, Katherine H. Tkaczuk, Patrick J. Ward, Glynn Wilson, Gerald Garrett, Richard T. Kenney, Priyanka Sharma. Clinical Cancer Research

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer<sup>☆</sup>. P. A. Francis, O. Pagani, G. F. Fleming, B. A. Walley, M. Colleoni, G. Rubovszky, C. Tondini, E. M. Ciruelos, H. L. Gomez, H. R. Bonnefoi, H. J. Burstein, C. Chini, F. Puglisi, S. Spazzapan, A. Bernardo, M. A. Climent, M. Bellet, T. Ruhstaller, B. Bermejo, S. K.L. Chia, S. Martino, C. E. Geyer, M. P. Goetz, J. N. Ingle, V. Stearns, N. E. Davidson, F. Le Du, B. Müller, R. E. Coleman, S. Loibl, E. P. Winer, B. Ruepp, S. Loi, I. Láng, A. S. Coates, R. D. Gelber, A. Goldhirsch, M. M. Regan, M. Colleoni, S. Loi, A. Hiltbrunner, S. Allemann, A. Gasca, R. Kammler, R. Maibach, M. Rabaglio-Poretti, H. Roschitzki, P. Klein, A. D. Tiersten, R. D. Hart. Annals of Oncology

Prescribing Trends of Adjuvant Neratinib in Hormone Receptor-Positive HER2-Positive Breast Cancer. Julia Blanter, Hulya Kocyigit, Lakshmi Kowtha, Malini Harigopal, Amy Tiersten. Oncology (Switzerland)

View All Publications

Amy Tiersten, MD

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Tiersten during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • DMC law
  • decof law firm
  • Astrazeneca
  • Novartis Pharmaceutical Corporation
  • cantor fitzgerald
  • beasley law firm
  • summers/schwartz law firm
  • Gilead Sciences
  • kaveny kroll law firm

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.